- Home
- NHC vs GLPG Comparison
NHC vs GLPG Comparison
Compare NHC & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHC
- GLPG
- Stock Information
- Founded
- NHC 1971
- GLPG 1999
- Country
- NHC United States
- GLPG Belgium
- Employees
- NHC N/A
- GLPG N/A
- Industry
- NHC Hospital/Nursing Management
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- NHC Health Care
- GLPG Health Care
- Exchange
- NHC Nasdaq
- GLPG Nasdaq
- Market Cap
- NHC 1.8B
- GLPG 2.1B
- IPO Year
- NHC N/A
- GLPG 2005
- Fundamental
- Price
- NHC $114.86
- GLPG $32.26
- Analyst Decision
- NHC
- GLPG Sell
- Analyst Count
- NHC 0
- GLPG 4
- Target Price
- NHC N/A
- GLPG $25.33
- AVG Volume (30 Days)
- NHC 42.9K
- GLPG 168.5K
- Earning Date
- NHC 11-07-2025
- GLPG 10-29-2025
- Dividend Yield
- NHC 2.21%
- GLPG N/A
- EPS Growth
- NHC 12.96
- GLPG N/A
- EPS
- NHC 6.70
- GLPG N/A
- Revenue
- NHC $1,458,155,000.00
- GLPG $323,674,692.00
- Revenue This Year
- NHC N/A
- GLPG N/A
- Revenue Next Year
- NHC N/A
- GLPG N/A
- P/E Ratio
- NHC $17.22
- GLPG N/A
- Revenue Growth
- NHC 24.46
- GLPG 5.43
- 52 Week Low
- NHC $89.14
- GLPG $22.36
- 52 Week High
- NHC $136.86
- GLPG $33.86
- Technical
- Relative Strength Index (RSI)
- NHC 61.25
- GLPG 51.29
- Support Level
- NHC $114.59
- GLPG $31.49
- Resistance Level
- NHC $122.10
- GLPG $33.63
- Average True Range (ATR)
- NHC 2.62
- GLPG 0.66
- MACD
- NHC -0.28
- GLPG -0.06
- Stochastic Oscillator
- NHC 34.12
- GLPG 50.18
About NHC National HealthCare Corporation
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.